AUTHOR=Cheng Yu-Xi , Tao Wei , Kang Bing , Liu Xiao-Yu , Yuan Chao , Zhang Bin , Peng Dong 

TITLE=Impact of Preoperative Type 2 Diabetes Mellitus on the Outcomes of Gastric Cancer Patients Following Gastrectomy: A Propensity Score Matching Analysis

JOURNAL=Frontiers in Surgery

VOLUME=9

YEAR=2022

URL=https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2022.850265

DOI=10.3389/fsurg.2022.850265

ISSN=2296-875X

ABSTRACT=<sec><title>Purpose</title><p>The current study aims to explore the outcomes of type 2 diabetes mellitus (T2DM) on gastric cancer patients following gastrectomy through propensity score matching (PSM) analysis.</p></sec><sec><title>Methods</title><p>A retrospective study of gastric cancer patients following gastrectomy was conducted in a single clinical center from January 2014 to December 2019. The short-term outcomes, overall survival (OS) and disease-free survival (DFS) were analyzed between T2DM group and Non-T2DM group.</p></sec><sec><title>Results</title><p>A total of 703 patients were enrolled in this study. After 1:1 PSM, 84 patients in T2DM group and 84 patients in Non-T2DM were matched for final analysis. No significant difference was found in terms of operation time, intra-operative blood loss, retrieved lymph nodes, postoperative stay, blood transfusion and complications between T2DM group and Non-T2DM group (<italic>p</italic> &gt; 0.05). The Kaplan-Meier curve implied that T2DM had no impact on OS or DFS. Cox regression was conducted to identify predictive factors for prognosis. Body mass index (BMI) (<italic>p</italic> = 0.039 &lt; 0.05, HR = 0.725, 95% CI = 0.534–0.983), pre-operative lymphocyte (<italic>p</italic> = 0.017 &lt; 0.05, HR = 0.678, 95% CI = 0.493–0.932), pathological tumor node metastasis (pTNM) stage (<italic>p</italic> = 0.000 &lt; 0.05, HR = 2.619, 95% CI = 2.048–3.349) and complications (<italic>p</italic> = 0.006 &lt; 0.05, HR = 1.528, 95% CI = 1.132–2.061) were predictive factors for OS, and BMI (<italic>p</italic> = 0.013 &lt; 0.05, HR = 0.524, 95% CI = 0.315–0.872), pTNM stage (<italic>p</italic> = 0.000 &lt; 0.05, HR = 2.619, 95% CI = 2.048–3.349) and complications (<italic>p</italic> = 0.008 &lt; 0.05, HR = 1.892, 95% CI = 1.179–3.036) were independent predictive factors for DFS.</p></sec><sec><title>Conclusion</title><p>T2DM did not have an impact on gastric cancer patients following gastrectomy in terms of short-term outcomes and prognosis.</p></sec>